Shernan Holtan, MD

Medical experts discuss multidisciplinary approaches to GVHD.

Medical experts discuss the role of patient-reported outcomes in cGVHD.

Medical experts discuss emerging trends in chronic GVHD treatment.

Medical experts discuss the mechanism of action within axatilimab.

Medical experts discuss the recent updates presented at ASH 2023 and TANDEM 2024.

Medical experts discuss treatment selection for a specific clinical scenario.

Medical experts discuss considerations for third-line treatment in chronic GVHD.

Medical experts discuss the data that led to belumosudil’s FDA approval.

Medical experts discuss advanced therapies in cGVHD.

Medical experts discuss criteria for switching GVHD treatments and how to choose between available treatment options.

Medical experts discuss overall goals for cGVHD treatment as well as concerns with long-term corticosteroid use in treatment.

Medical experts discuss navigating chronic GVHD.

After a brief introduction, Shernan Holtan, MD, and Haris Ali, MD, discuss the distinction between acute and chronic graft-vs-host disease.